Acro Biomedical Co., Ltd.
ACBM· OTC
ACBMAcro Biomedical Co., Ltd.
Filed Aug 11, 2017 · 10-Q · 42 days after period end · 0001640334-17-001625
| Metric | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|
| Net Income | -$11.89K | -$17.13K | -$18.00 |
| EPS Diluted | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Acro Biomedical Co., Ltd. · CIK 1622996 · Engraved from SEC EDGAR
ended Jun 30, 2017 · filed Aug 11, 2017 · 42 d after period end
